In a glioblastoma model, the inhibitory action of curcumin on tumorigenesis in vivo was characterized by an inhibition of the p-AKT/mTOR pathway and enhancement of the expression of the tumor suppressor protein tp53 [68]. The gene discussed is AKT1; the disease is glioblastoma.